Intraperitoneal
adhesions are common and serious complications
after surgery. Deposition of proteins and inflammatory response on
an injured cecum are the main factors resulting in the formation of
adhesion. In this study, purely zwitterionic hydrogels (Z-hydrogels)
are developed using thiolated poly(sulfobetaine methacrylate-co-2-((2-hydroxyethyl)disulfanyl)ethyl methacrylate) [poly(SBMA-co-HDSMA)] as the network backbone and divinyl-functionalized
sulfobetaine (BMSAB) as the zwitterionic cross-linker via the thiol–ene
click reaction. To improve the anti-inflammatory activity, cefoxitin
sodium is loaded into Z-hydrogels (Z/C-hydrogel) to construct the
physical barrier/drug system. The gelation time, mechanical behavior,
and swelling ratio of the prepared Z-hydrogel can be modulated via
adjusting the SBMA/HDSMA ratio in the copolymer. Moreover, they not
only exhibit excellent resistance to protein and fibroblast adhesion
but also show good biocompatibility and hemocompatibility. To assess
its anti-adhesion effects in vivo, the Z-hydrogel is injected on the
injured cecum surface using a rat model of sidewall defect-cecum abrasion.
The results show that the Z-hydrogel can completely cover the irregular
cecum surface and effectively suppress the formation of postoperative
adhesion via reducing protein deposition and resisting fibroblast
adhesion. Moreover, the introduction of cefoxitin sodium decreases
the inflammatory response after surgery, thus further improving the
anti-adhesion effect. Overall, we suggest that the Z-hydrogel is a
promising candidate for the prevention of a postsurgical peritoneal
adhesion.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.